Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

被引：0
|
作者：
Van Gelder, Michel [1 ]
Schetelig, Johannes [2 ]
Volin, Liisa [3 ]
Maertens, Johan [4 ]
Socie, Gerard [5 ]
Petersen, Eefke [6 ]
Thomssen, Henrike [7 ]
Biezen, Anja [8 ]
Brand, Ronald [8 ]
de Witte, T. M. [9 ]
Kroeger, Nicolaus [10 ]
机构：
[1] Univ Limburg, Acad Hosp Maastricht, Maastricht, Netherlands
[2] Univ Hosp Dresden, Dresden, Germany
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Univ Gasthuisberg, Louvain, Belgium
[5] Hop St Louis, Paris, France
[6] Univ Med Ctr Utrecht, Utrecht, Netherlands
[7] Klinikum Bremen Mitte, Med Klin 1, Bremen, Germany
[8] EBMT, CLWP, Data Off Leiden, Leiden, Netherlands
[9] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[10] Univ Med Ctr Hamburg, Hamburg, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [1] Reduced versus standard conditioning followed by allogeneic stem cell transplantation in MDS/sAML. A prospective randomised phase III study of the MDS subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplant
    Kroeger, N.
    Brand, R.
    van Os, M.
    Barois, A.
    Niederwieser, D.
    Ruutu, T.
    Symeonidis, A.
    Onida, F.
    Garderet, L.
    de Witte, T.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S38 - S39
  • [2] Monosomal karyotype, higher blast count and ex vivo T-cell depletion predict poor outcome after allogeneic stem cell transplantation for MDS/SAML patients with chromosome 7 abnormalities
    van Gelder, M.
    Schetelig, J.
    Volin, L.
    Maertens, J.
    Socie, G.
    Petersen, E.
    Thomssen, H.
    Biezen, A.
    Brand, R.
    de Witte, T.
    Kroeger, N.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S62 - S62
  • [3] Allogeneic stem cell transplantation from unrelated donors after reduced intensity conditioning in patients with MDS/sAML. A report from the chronic leukemia working party (CLWP) of the EBMT.
    Kroeger, N
    Brand, R
    Martino, R
    Guardiola, P
    van Biezen, A
    Zander, A
    Niederwieser, D
    De Witte, T
    [J]. BLOOD, 2004, 104 (11) : 378B - 378B
  • [4] Complex Karyotype Predicts Outcome Better Than Monosomal Karyotype In Patients with MDS/Secondary Acute Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): a Retrospective Survey on Behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Brands-Nijenhuis, Angelique V. M.
    van Gelder, Michel
    de Witte, Theo M.
    Schetelig, Johannes
    van Biezen, Anja
    Kroeger, Nicolaus
    [J]. BLOOD, 2010, 116 (21) : 255 - 256
  • [5] Allogeneic stem cell transplantation for therapy-related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia. A report from the MDS subcommittee of the chronic leukemia working party of the European group for blood and marrow transplantation (EBMT)
    Kroeger, Nicolaus
    Brand, Ronald
    van Biezen, Anja
    Niederwieser, Dietger
    de Witte, Theo
    [J]. BLOOD, 2007, 110 (11) : 81A - 81A
  • [6] Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP)
    Kroeger, N.
    Putter, H.
    de Wreede, L.
    van Biezen, A.
    Ziagkos, D.
    Volin, L.
    Maertens, J.
    Finke, J.
    Ljungman, P.
    Russell, N.
    Yakoub-Agha, I.
    Schaap, M.
    Craddock, C.
    Mufti, G.
    Chevallier, P.
    Passweg, J.
    Milpied, N.
    Blaise, D.
    Bourhis, J. H.
    Gedde-Dahl, T.
    Espiga, C. R.
    Cornelissen, J.
    Goehring, G.
    Schetelig, J.
    de Witte, T.
    Robin, M.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S310 - S311
  • [7] Relapse Risk Score after Allogeneic Stem Cell Transplantation for MDS Patients. an EBMT Study from the MDS Subcommittee of Chronic Malignancies Working Party (CMWP)
    Kroger, Nicolaus
    Putter, Hein
    De Wreede, Liesbeth
    van Biezen, Anja
    Ziagkos, Dimitris
    Volin, Liisa
    Maertens, Johan
    Finke, Jurgen
    Ljungman, Per T.
    Russell, Nigel H.
    Yakoub-Agha, Ibrahim
    Schaap, Michel
    Craddock, Charles
    Mufti, Ghulam J.
    Chevallier, Patrice
    Passweg, Jakob R.
    Milpied, Noel
    Blaise, Didier
    Bourhis, Jean-Henri
    Gedde-Dahl, Tobias
    Espiga, Carlos Richard
    Cornelissen, Jan J.
    Gohring, Gudrun
    Schetelig, Johannes
    de Witte, Theo
    Robin, Marie
    [J]. BLOOD, 2016, 128 (22)
  • [8] Bone marrow fibrosis on outcomes of patients with MDS/sAML undergoing allogeneic stem cell transplantation
    Kroeger, N.
    Zabelina, T.
    van Biezen, A.
    Brand, R.
    de Witte, T.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S62 - S62
  • [9] HLA-identical sibling Stem Cell Transplantation (SCT) in patients with Myelodysplastic Syndromes (MDS) or secondary Acute Myeloid Leukemia (sAML): a report from the MDS study group of the EBMT chronic leukemia working party
    Runde, V
    de Witte, T
    Brand, R
    van Biezen, A
    Bacigalupo, A
    Ruutu, T
    Willemze, R
    Guardiola, P
    Boogaerts, MA
    Cordonnier, C
    Alessandrino, EP
    Gratwohl, A
    Reiffers, J
    Finke, J
    Arnold, R
    Niederwieser, D
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S69 - S69
  • [10] Allogeneic stem cell transplantation for therapy-related Myelodysplastic Syndrome (T-MDS) and acute myeloid leukemia (T-AML).: A report from the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Kroeger, N.
    [J]. ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
12345